After demonstrating activation of the oncogenic MAPK pathway by knocking down CXCR4 expression, we investigated phenotypic changes in MCF7 breast cancer cells co-cultivated with THP-1 cells expressing reduced levels of CXCR4. The gene discussed is CXCR4; the disease is breast cancer.